All ENT Notes & Lectures

Hurthle cell Carcinoma of Thyroid

Buy my ENT Notes

🇮🇳 For Indian Students

- To buy the notes, click here

💡 The post below is just an outline of the YouTube video and my notes. For the full content, please purchase the notes using the links above.

🧬 Hurthle Cell Carcinoma of Thyroid

📖 Definition of Hurthle Cell Carcinoma of Thyroid

Hurthle Cell Carcinoma is a malignant thyroid tumor composed predominantly of Hurthle cells.

It accounts for 3–10% of all differentiated thyroid cancers.

What are Hurthle cells?

What are some other names of Hurthle cells?


🧠 Historical Background

  • Previously classified as: A variant of follicular carcinoma.

  • Now (WHO classification): Recognized as an independent tumor type due to:

    • Distinct molecular alterations
    • Different biological behavior
    • Unique clinical course

Where does Hurthle Cell Carcinoma of Thyroid originate from?


👩‍🦳 Epidemiology of Hurthle Cell Carcinoma of Thyroid

  • Age: More common in elderly individuals

  • Sex: Predominantly females

  • Incidence: 3–10% of differentiated thyroid malignancies


🔬 Cytological & Histological Features of Hurthle Cell Carcinoma of Thyroid

🔹 Hurthle Cells — The Characteristic Cell

What is the microscopic appearance of Hurthle cells?

🧫 Microscopy

  • The tumor is usually encapsulated with a thick capsule.

  • Sheets or nests of Hurthle cells with granular cytoplasm are seen.

  • Capsular or vascular invasion must be demonstrated to confirm carcinoma (similar to follicular carcinoma).

📸 Key Diagnostic Point:
The presence of capsular and/or vascular invasion differentiates Hürthle cell carcinoma from Hürthle cell adenoma.


🩺 Clinical Features of Hurthle Cell Carcinoma of Thyroid

Patients usually present with:

  • A thyroid nodule, which can be:

    • Solitary or multifocal
    • Unilateral or bilateral
  • The swelling is typically firm and non-tender.

  • More aggressive course than follicular carcinoma.

  • Local invasion and recurrence are common.

Metastatic Spread:

  • Hematogenous spread: To lungs, bone, liver

  • Lymphatic spread: More common than in follicular carcinoma


🔍 Investigations of Hurthle Cell Carcinoma of Thyroid

  1. Fine Needle Aspiration Cytology (FNAC)
  • Shows presence of Hurthle cells.
  • Cannot differentiate between adenoma and carcinoma — histological evidence of capsular/vascular invasion is essential.
  1. CT Scan / MRI Neck
  • Evaluates local extension and regional lymph nodes.
  1. Bone Scan
  • To detect bony metastases.

🧠 Note: Hurthle cell carcinoma may show reduced iodine uptake on radioisotope scanning.


💊 Treatment of Hurthle Cell Carcinoma of Thyroid

1️⃣ Surgery — Mainstay of Treatment

  • Total Thyroidectomy is the treatment of choice.

Why is Total Thyroidectomy the treatment of choice in Hurthle Cell Carcinoma of Thyroid?

2️⃣ Radioiodine Ablation

  • Not effective in most cases

Why is radioiodine therapy of limited benefit in Hurthle Cell Carcinoma of Thyroid?

3️⃣ Thyroid Hormone Suppression Therapy

  • Lifelong TSH suppression with Levothyroxine is essential
    • Prevents stimulation of residual tumor cells.

📉 Prognosis of Hurthle Cell Carcinoma of Thyroid

Hürthle Cell Carcinoma has a worse prognosis compared to follicular carcinoma.

Why does Hurthle Cell Carcinoma of Thyroid have the worst prognosis?


🧾 Summary Table

FeatureHürthle Cell Carcinoma
Cell of OriginFollicular epithelial cells
Cell TypeHurthle cells
NatureMalignant tumor
Capsular/Vascular invasionRequired for diagnosis
Common inElderly women
SpreadBoth hematogenous & lymphatic
Radioiodine uptakePoor
TreatmentTotal thyroidectomy + lifelong TSH suppression
PrognosisPoorer than follicular carcinoma
~~~~~~~~

📝 All the topics and questions mentioned in this post are explained in detail in my ENT notes - built for exam success and clinical understanding. Get full access by purchasing the notes.

Buy my ENT Notes

🇮🇳 For Indian Students

- To buy the notes, click here
~~~~~~~~

Related ENT Notes & Lectures